|
Volumn 5 Suppl 1, Issue , 2006, Pages
|
Targeting growth factor and antiangiogenic pathways in clear-cell renal cell carcinoma: rationale and ongoing trials.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
MONOCLONAL ANTIBODY;
PROTEIN KINASE INHIBITOR;
VASCULOTROPIN A;
ANIMAL;
CLINICAL TRIAL;
DRUG EFFECT;
HUMAN;
KIDNEY CARCINOMA;
KIDNEY TUMOR;
NEOVASCULARIZATION (PATHOLOGY);
REVIEW;
ANGIOGENESIS INHIBITORS;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
CARCINOMA, RENAL CELL;
CLINICAL TRIALS;
HUMANS;
KIDNEY NEOPLASMS;
NEOVASCULARIZATION, PATHOLOGIC;
PROTEIN KINASE INHIBITORS;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
MLCS;
MLOWN;
|
EID: 34047223606
PISSN: 15587673
EISSN: None
Source Type: Journal
DOI: 10.3816/CGC.2006.s.005 Document Type: Article |
Times cited : (10)
|
References (89)
|